The gluten-free diet is associated with clinical, economic and social issues.
The most advanced therapies include gluten enzymatic digestion and barrier protection.
New therapies target gluten toxicity, immune responses and the intestinal microbiota.
Choice of therapy will depend on clinical phenotype and risk factors.